Group A Streptococcus (GAS, Streptococcus pyogenes) is a bacterial pathogen responsible for a range of diseases including rheumatic fever and rheumatic heart disease. A vaccine has been developed and is currently under phase 1 human clinical trial in healthy adults to assess the safety and immunogenicity of this formulation.
Related links
- Quest for a rheumatic heart disease cure hits fever pitch - The Courier Mail, 12 January 2013.
Search Research Topic:
Created: 17 July 2012 - Updated: 10 May 2013